Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes.

Afshinnia F, Reynolds EL, Rajendiran TM, Soni T, Byun J, Savelieff MG, Looker HC, Nelson RG, Michailidis G, Callaghan BC, Pennathur S, Feldman EL

Open source

DOI
10.1002/acn3.51639
Published
2022 Sep
Container
Annals of clinical and translational neurology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/acn3.51639,
  title = {Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes.},
  author = {Afshinnia F and Reynolds EL and Rajendiran TM and Soni T and Byun J and Savelieff MG and Looker HC and Nelson RG and Michailidis G and Callaghan BC and Pennathur S and Feldman EL},
  year = {2022},
  journal = {Annals of clinical and translational neurology},
  doi = {10.1002/acn3.51639},
  url = {https://doi.org/10.1002/acn3.51639}
}

RIS

TY  - JOUR
TI  - Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes.
AU  - Afshinnia F
AU  - Reynolds EL
AU  - Rajendiran TM
AU  - Soni T
AU  - Byun J
AU  - Savelieff MG
AU  - Looker HC
AU  - Nelson RG
AU  - Michailidis G
AU  - Callaghan BC
AU  - Pennathur S
AU  - Feldman EL
PY  - 2022
JO  - Annals of clinical and translational neurology
DO  - 10.1002/acn3.51639
UR  - https://doi.org/10.1002/acn3.51639
ER  - 

APA

F, A., EL, R., TM, R., T, S., J, B., MG, S., HC, L., RG, N., G, M., BC, C., S, P., & EL, F. (2022). Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes.. Annals of clinical and translational neurology. https://doi.org/10.1002/acn3.51639

Source records